Australian Clinical Labs Ltd

ASX:ACL (Australia)  
A$ 2.37 (-3.27%) Jul 16
30.78
P/B:
2.88
Market Cap:
A$ 494.49M ($ 333.48M)
Enterprise V:
A$ 796.59M ($ 537.20M)
Volume:
2.03M
Avg Vol (2M):
759.08K
Trade In:
Volume:
2.03M
Avg Vol (2M):
759.08K

Australian Clinical Labs Ltd Stock Institutional Ownership and Insider Ownership -

22.0746
(Mil)
Short Interest
10.94
22.07 (Mil)
Short % of Shares Outstanding
201.83
(Mil)
Shares Outstanding
22.99%
46.10 (Mil)
Institutional Ownership

Short Interest History (%)

Due to a license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus’ website, except for certain Australian stocks.

Institutional Ownership History (%)

This the Institutional Ownership History of Australian Clinical Labs Ltd. Peter Lynch prefers to buy companies with low institutional ownership.
* Due to varying ownership data coverage and corporate events such as splits, the information in this section is in no way guaranteed for completeness, accuracy or in any other way.

Insider ownership (%)

This is the historical insider ownership of Australian Clinical Labs Ltd. It is usually better to buy companies with large insider ownership. The company insiders' interest are more aligned with external shareholders in this case.
1. Please note that our data vendor collects insider data for officers and directors from Forms 3,4,5 and amendments where they only capture direct ownership data, not indirect ownership.
* Due to varying ownership data coverage and corporate events such as splits, the information in this section is in no way guaranteed for completeness, accuracy or in any other way.

Top Direct Holders

Top Fund Holders